The event highlighted healthcare AI’s shift from experimentation to real-world deployment, with discussions on accountability, governance, workforce readiness and exhibitor solutions including Heidi and AITRICS-VC....
The NMPA designation advances NHWD-870 HCI, an oral BET inhibitor for advanced thoracic NUT carcinoma, following Phase II data showing anti-tumour activity and survival benefit in a rare, aggressive cancer with limited treatment options. ...
The Tokyo office will support Japanese biopharmaceutical companies across the product lifecycle, combining market access, medical, marketing and strategic consulting capabilities under the leadership of Junji Yokokawa. ...
India Sebia, in collaboration with CAHO Diagnostic Division, is proud to announce the launch of the Autoimmunity Masterclass Series—a six-part academic webinar initiative aimed at advancing the understanding, early diagnosis, and clinical management of autoimmune diseases....
Jointly developed by SGH, SingHealth and MOHT, LEA-Net uses patient data to identify individuals at higher risk of lower extremity amputation three to five years before foot ulcers and infections develop. ...
NuvioDx will support the deployment of Nanox.ARC multi-source digital tomosynthesis systems across clinical sites in various states...
15 world-first discoveries transform our understanding of physiological reactions to neurologically active substances that, when consumed, affect the central nervous system and speech...
Esperto Medical receives ARPA-H SBIR funding to develop a continuous, noninvasive wearable blood pressure monitor, leveraging its proprietary resonance-based technology to enable calibration-free, real-time cardiovascular monitoring....
Collaboration combines Profluent's frontier AI platform with Lilly's leading capabilities in genetic medicines...
Focus on real-time data insights and connected monitoring underscores shift toward precision cardiac care and improved clinical decision-making...
